Recombinant Human SMOCs Produced by in Vitro Refolding: Calcium-binding Properties and Interactions with Serum Proteins
Overview
Affiliations
Secreted modular calcium-binding (SMOC) proteins are little known members of the BM-40 family of matricellular proteins. SMOC-1 is localized in basement membranes, while SMOC-2 exhibits pro-angiogenic properties and stimulates cell cycle progression via integrin-linked kinase. In this work we have expressed recombinant human SMOCs in inclusion bodies in Escherichia coli. Soluble proteins were prepared by in vitro refolding with a final yield of approximately 3mg of purified SMOCs per liter of bacterial culture. The folding state of the products and their ability to reversibly bind calcium ions were verified by CD spectroscopy. The EF hands of the refolded SMOCs were both functional, one had high affinity for calcium ions (K(d) values in the 0.7-1 microM range), while the other had lower affinity (K(d) values 20-25 microM). The proteins were also examined for their ability to bind blood serum proteins. Three of the bands specifically retained on SMOC-Sepharose were identified as C-reactive protein, an acute phase protein from the pentraxin family, the basement membrane and elastic fiber-associated fibulin-1, and vitronectin, which is involved in cell adhesion, migration and proliferation and binds numerous extracellular and membrane proteins, including integrins. The interactions were additionally confirmed in solution using purified individual proteins by the method of biotin label transfer from one interacting partner to the other. Their identification is among the first pieces of information about the action of the SMOCs on molecular level and opens new possibilities for future research aimed towards elucidating the physiological roles of these versatile proteins.
SMOC1 colocalizes with Alzheimer's disease neuropathology and delays Aβ aggregation.
Balcomb K, Johnston C, Kavanagh T, Leitner D, Schneider J, Halliday G Acta Neuropathol. 2024; 148(1):72.
PMID: 39585417 PMC: 11588930. DOI: 10.1007/s00401-024-02819-6.
Miao X, Alidadipour A, Saed V, Sayyadi F, Jadidi Y, Davoudi M Acta Diabetol. 2024; 61(11):1339-1361.
PMID: 39031190 DOI: 10.1007/s00592-024-02335-9.
Secreted modular calcium-binding proteins in pathophysiological processes and embryonic development.
Gao Q, Mok H, Zhuang J Chin Med J (Engl). 2019; 132(20):2476-2484.
PMID: 31613820 PMC: 6831058. DOI: 10.1097/CM9.0000000000000472.
SMOC2 inhibits calcification of osteoprogenitor and endothelial cells.
Peeters T, Monteagudo S, Tylzanowski P, Luyten F, Lories R, Cailotto F PLoS One. 2018; 13(6):e0198104.
PMID: 29897942 PMC: 5999237. DOI: 10.1371/journal.pone.0198104.
SMOC can act as both an antagonist and an expander of BMP signaling.
Thomas J, Dollins D, Andrykovich K, Chu T, Stultz B, Hursh D Elife. 2017; 6.
PMID: 28323621 PMC: 5360445. DOI: 10.7554/eLife.17935.